Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Neutralizing gut bacterial fragments reduces autoimmunity

March 6, 2019

Tackling tendonitis

March 5, 2019

RUNX1 mRNA-containing nanomicelles prevent intervertebral disk degeneration in mice

March 5, 2019

Lupus Therapeutics collaborates with Takeda on phase I trial of TAK-079 for SLE

March 4, 2019

Bristol-Myers Squibb presents lysophospholipid S1P1 receptor agonists

March 4, 2019

Azetidine optimization leads to clinical candidate JTE-952 for rheumatoid arthritis

March 1, 2019

Miransertib shows promising therapeutic efficacy in children with Proteus syndrome

Feb. 28, 2019

Nodthera patents NLRP3 inflammasome inhibitors

Feb. 28, 2019

Toll-like receptor 7/8/9 antagonists discovered at Bristol-Myers Squibb

Feb. 26, 2019

Bristol-Myers Squibb identifies TLR7/8/9 antagonists

Feb. 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...